Tag Archive for: pharmaceuticals
https://pioneerinstitute.org/wp-content/uploads/Blog-drug-prices-RD-Smith-012220242.png 1400 1400 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2024-01-22 10:09:202024-01-22 10:09:20‘High’ U.S. Drug Prices Mask Freeloading by Other Nations
The drug company’s choice is to walk away from millions in revenue from a given country and deny their people a lifesaving drug, or swallow hard and accept an unfair price that is nowhere near the drug’s value. For the sake of shareholders and patients, drug companies typically accept the unfair price and devote the revenue to offsetting their previous investments. In short, other nations are freeloading off of American R&D.
https://pioneerinstitute.org/wp-content/uploads/Screenshot-2023-06-12-at-10.53.19-AM.png 818 1260 William Smith https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png William Smith2023-06-12 10:58:462023-06-12 10:58:46Opinion: Legislature should act on bill to limit out-of-pocket drug costs
S. 609, a bill that would limit out-of-pocket costs for patients paying for prescription drugs, is a clear step in the right direction. Massachusetts should join 16 other states that have passed similar bills to protect patients.
https://pioneerinstitute.org/wp-content/uploads/Hubwonk-Template-36.png 512 1024 Editorial Staff https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png Editorial Staff2021-08-24 07:52:382021-08-24 07:52:38Targeting Pharma: Infrastructure Bill Employs Price Controls To Offset Unprecedented Price Tag
Hubwonk host Joe Selvaggi talks with Pioneer Institute Visiting Fellow in Life Sciences Dr. William Smith about how the price control features of the emerging $3.5 trillion infrastructure bill might affect the pharmaceutical Industry, both nationwide and here in Massachusetts, and what effect that change will have on drug consumers.